11/25/2024 | Press release | Distributed by Public on 11/25/2024 07:01
For the reasons set forth in the accompanying Proxy Statement, our Board of Directors recommends that you vote "FOR" Proposals 1, 2 and 3 on the agenda for the Meeting.
|
Very truly yours,
Joseph Turk
Chairman of the Board of Directors
November 25, 2024
|
|
1. |
To amend the Company's Sixth Amended and Restated Articles of Association to eliminate the par value of the Company's ordinary shares.
|
|
2. |
To approve the Company's 2024 Incentive Compensation Plan.
|
|
3. |
To approve a grant to Larry Jasinski, the Company's Chief Executive Officer, of 14,286 restricted stock units ("RSUs") and 14,285 performance-based RSUs.
|
|
4. |
To act upon any other matters that may properly come before the Meeting or any adjournment or postponement thereof.
|
For the reasons set forth in the accompanying Proxy Statement, our Board of Directors recommends that you vote "FOR" Proposals 1, 2 and 3 on the agenda for the Meeting.
|
By Order of the Board of Directors,
Joseph Turk
Chairman of the Board of Directors
November 25, 2024
|
QUESTIONS AND ANSWERS ABOUT THE MEETING
|
2
|
DATE THESE PROXY MATERIALS ARE FIRST BEING MAILED
|
6
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
|
7
|
PROPOSAL 1 - APPROVAL OF AN AMENDMENT TO THE COMPANY'S SIXTH AMEDED AND RESTATED ARTICLES OF ASSOCIATION TO ELIMINATE THE PAR VALUE OF THE COMPANY'S ORDINARY SHARES
|
9
|
PROPOSAL 2 - APPROVAL OF THE COMPANY'S 2024 INCENTIVE COMPENSATION PLAN
|
10
|
PROPOSAL 3 - APPROVAL OF A GRANT OF EQUITY AWARDS TO LARRY JASINSKI, OUR CEO
|
17
|
OTHER BUSINESS
|
18
|
ADDITIONAL INFORMATION
|
18
|
APPENDIX A - 2024 INCENTIVE COMPENSATION PLAN
|
A-1
|
|
1. |
To amend the Company's Sixth Amended and Restated Articles of Association to eliminate the par value of the Company's ordinary shares.
|
|
2. |
To approve the Company's 2024 Incentive Compensation Plan.
|
|
3. |
To approve a grant to Larry Jasinski, the Company's Chief Executive Officer, of 14,286 restricted stock units ("RSUs") and 14,285 performance-based RSUs.
|
|
4. |
To act upon any other matters that may properly come before the Meeting or any adjournment or postponement thereof.
|
Q: |
When and where is the Extraordinary General Meeting of Shareholders being held?
|
A: |
The Meeting will be held on Monday, December 30, 2024, at 10:00 a.m. (Eastern Standard Time), at the Company's offices at 200 Donald Lynch Blvd., Marlborough, MA 01752, U.S.A. As always, we encourage you to vote your shares prior to the Meeting. We intend to hold the Meeting in person. In the event it is not possible or advisable to hold the Meeting in person, we will announce alternative arrangements for the meeting as promptly as practicable, which may include holding the meeting solely by means of remote communication.
|
Q: |
Who can attend the Meeting?
|
A: |
Any shareholder of the Company as of the Record Date (as defined above) may attend. Please note that space limitations make it necessary to limit attendance to shareholders. Admission will be on a first-come, first-served basis. Current proof of ownership of Lifeward's shares as of the Record Date, as well as a form of personal photo identification, must be presented in order to be admitted to the Meeting. If your shares are held in the name of a bank, broker or other holder of record, you must bring a current brokerage statement or other form of proof reflecting ownership as of the Record Date with you to the Meeting. No cameras, recording equipment, electronic devices, use of cell phones or other mobile devices, large bags or packages will be permitted at the Meeting.
|
Q: |
Who is entitled to vote?
|
A: |
Only holders of Lifeward's ordinary shares at the close of business on the Record Date are entitled to notice of, and to vote at, the Meeting and any adjournment or postponement thereof. Each shareholder is entitled to one vote for each ordinary share owned as of the Record Date. Ordinary shares held in our treasury, which are not considered outstanding, will not be voted. On November 20, 2024, there were 8,808,143 ordinary shares outstanding entitled to vote and there were no outstanding shares of any other class.
|
A: |
You may vote in person. Ballots will be passed out at the Meeting to anyone who wants to vote at the Meeting. If you choose to do so, please bring the enclosed proxy card or proof of identification. If you are a shareholder of record, meaning that your shares are held directly in your name, you may vote in person at the Meeting. However, if your shares are held in "street name" (that is, through a bank, broker or other nominee), you must first obtain a signed proxy from the record holder (that is, your bank, broker or other nominee) before you vote at the Meeting.
|
Q: |
What is the difference between holding shares as a shareholder of record and holding shares in "street name"? Will my shares be voted if I do not provide my proxy?
|
A: |
Many Lifeward shareholders hold their shares in "street name," meaning through a bank, broker or other nominee rather than directly in their own name. As explained in this Proxy Statement, there are some distinctions between shares held of record and shares owned in "street name."
|
Q: |
Does Lifeward recommend I vote in advance of the Meeting?
|
A: |
Yes. Even if you plan to attend the Meeting, we recommend that you vote your shares in advance so that your vote will be counted if you later decide not to attend the Meeting.
|
Q: |
If I vote by proxy, can I change my vote or revoke my proxy?
|
A: |
Yes. You may change your proxy instructions at any time prior to the vote at the Meeting. If you are a shareholder of record, you may do this by:
|
|
• |
filing a written notice of revocation with our Chief Financial Officer, delivered to our address above;
|
|
• |
delivering a timely later-dated proxy card or voting instruction form; or
|
|
• |
attending the Meeting and voting (attendance at the Meeting will not cause your previously granted proxy to be revoked unless you specifically so request).
|
Q: |
How are my votes cast when I submit a proxy vote?
|
A: |
When you submit a proxy vote, you appoint Larry Jasinski and Michael Lawless, or either of them, as your representative(s) at the Meeting. Your shares will be voted at the Meeting as you have instructed.
|
Q: |
What does it mean if I receive more than one proxy card from the Company?
|
A: |
It means that you have multiple accounts at the transfer agent or with brokers. Please sign and return all proxy cards to ensure that all of your shares are voted.
|
Q: |
What constitutes a quorum?
|
A: |
In order for us to conduct business at the Meeting, two or more shareholders must be present, in person or by proxy, representing at least 33-1/3% of the ordinary shares outstanding as of the Record Date. This is referred to as a quorum.
|
Q: |
What happens if a quorum is not present?
|
A: |
If a quorum is not present, the Meeting will be adjourned to the same day at the same time the following week, or to such day and at such time and place as the Chairman of the meeting may determine with the consent of the holders of a majority of the shares present in person or by proxy and voting on the question of adjournment.
|
Q: |
How will votes be counted?
|
A: |
Each outstanding ordinary share is entitled to one vote for each proposed resolution to be voted on at the Meeting. Our Articles of Association do not provide for cumulative voting.
|
Q: |
What are the requirements for approval of each of the proposals and how will votes (and discretionary voting) be handled?
|
A: |
The following chart details the votes required for each of the proposals, the treatment of abstentions and broker non-votes for each of the proposals, and whether the proposals permit discretionary voting.
|
Proposal
|
Votes Required
|
Treatment of Abstentions and Broker Non-Votes
|
Broker Discretionary Voting
|
Proposal 1: Approval of an amendment to the Company's Sixth Amended and Restated Articles of Association to eliminate the par value of the Company's ordinary shares.
|
Affirmative vote of an Ordinary Majority.
|
Abstentions and broker non-votes will have no effect on the outcome of the vote.
|
Yes.
|
Proposal 2: Approval of the Company's 2024 Incentive Compensation Plan.
|
Affirmative vote of an Ordinary Majority.
|
Abstentions and broker non-votes will have no effect on the outcome of the vote.
|
No.
|
Proposal 3: Approval of a grant to Larry Jasinski, our Chief Executive Officer, of 14,286 RSUs and 14,285 performance-based RSUs.
|
Affirmative vote of an Ordinary Majority. In addition, a Special Majority, as discussed below, is required under Israeli law for approval of Proposal 3.
|
Abstentions and broker non-votes will have no effect on the outcome of the vote.
|
No.
|
Q: |
How will my shares be voted if I do not provide instructions on the proxy card?
|
A: |
If you are the record holder of your shares and return a properly executed proxy card to us no later than 10:00 a.m. (Eastern Standard Time) on the business day before the Meeting, but do not specify on your proxy card how you want to vote your shares, your shares will be voted as to each of the proposals in accordance with the recommendation of the Board, as follows:
|
Q: |
Where do I find the voting results of the Meeting?
|
A: |
We plan to announce preliminary voting results at the Meeting. The final voting results will be reported following the Meeting on the "Investors" portion on our website at www.golifeward.com and in a Current Report on Form 8-K that we expect to file with the Securities and Exchange Commission (the "SEC") within four business days after the Meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the Meeting, we intend to file a Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results.
|
Q: |
Who will bear the costs of solicitation of proxies for the Meeting?
|
A: |
Lifeward will bear the costs of solicitation of proxies for the Meeting. In addition to solicitation by mail, directors, officers and employees of Lifeward may solicit proxies from shareholders by telephone, in person or otherwise. Such directors, officers and employees will not receive additional compensation, but may be reimbursed for reasonable out-of-pocket expenses in connection with such solicitation. Brokers, nominees, fiduciaries and other custodians have been requested to forward soliciting material to the beneficial owners of ordinary shares held of record by them, and such custodians will be reimbursed by Lifeward for their reasonable out-of-pocket expenses.
|
Q: |
Who can I contact for more information or questions about the Meeting or the Proposals on the agenda for the Meeting?
|
A: |
For more information or questions about the Meeting or any of the Proposals on the agenda for the Meeting, please contact the Company's Chief Financial Officer by telephone at phone number +508-281-7274 or by email at [email protected].
|
Q: |
Can a shareholder express an opinion on a proposal prior to the Meeting?
|
A: |
In accordance with the Israel Companies Law and regulations promulgated thereunder, any Lifeward shareholder may submit a position statement on its behalf, expressing its position on an agenda item for the Meeting, to Lifeward Ltd., 200 Donald Lynch Blvd., Marlborough, Massachusetts 01752, U.S.A, Attention: Chief Financial Officer, or by email to [email protected], no later than December 20, 2024. Position statements must be in English and otherwise must comply with applicable law. We will make publicly available any valid position statement that we receive.
|
Ordinary Shares Beneficially Owned
|
||||||||
Name
|
Number of Shares
|
Percentage
|
||||||
5%-or-More Beneficial Owners:
|
||||||||
Lind Global Funds(1)
|
1,431,106
|
16.2
|
%
|
|||||
Named Executive Officers and Directors:
|
||||||||
Larry Jasinski(2)
|
61,705
|
*
|
||||||
Randel Richner(3)
|
25,852
|
*
|
||||||
Dr. John William Poduska(4)
|
20,102
|
*
|
||||||
Joseph Turk(5)
|
27,134
|
*
|
||||||
Hadar Levy(6)
|
15,656
|
*
|
||||||
Michael Swinford(7)
|
5,020
|
*
|
||||||
Robert J. Marshall(8)
|
-
|
-
|
||||||
Almog Adar(9)
|
16,516
|
*
|
||||||
Jeannine Lynch(10)
|
18,641
|
*
|
||||||
Michael A. Lawless (11)
|
26,112
|
*
|
||||||
Charles Remsberg(12)
|
7,142
|
*
|
||||||
All directors and executive officers as a group (eleven) persons) (13)
|
223,880
|
2.5
|
%
|
(1)
|
Based on a Schedule 13D/A filed on September 28, 2023, and subsequent Form 4 filings, by Lind Global Fund II LP ("Global Fund II"), Lind Global Partners II LLC, Lind Global Macro Fund LP, Lind Global Partners LLC (together, the "Lind Global Funds") and Jeff Easton (together with the Lind Global Funds, the "Reporting Persons"). The foregoing excludes warrants to purchase 247,334 ordinary shares, because each of the warrants includes a provision limiting the holder's ability to exercise the warrants if such exercise would cause the holder to beneficially own greater than 9.99% of the ordinary shares then outstanding. Without such provisions, the Reporting Persons may have been deemed to have beneficial ownership of the ordinary shares underlying such warrants. Jeff Easton, the managing member of Lind Global Partners II LLC and Lind Global Partners LLC, may be deemed to have sole voting and dispositive power with respect to the shares held by Lind Global Macro Fund, LP and Lind Global Fund II LP. The principal business address of the Reporting Persons is 444 Madison Avenue, Floor 41, New York, N.Y. 10022.
|
(2)
|
Consists of 57,969 ordinary shares, including exercisable options to purchase 3,736 ordinary shares.
|
(3)
|
Consists of 25,852 ordinary shares.
|
(4)
|
Consists of 20,033 ordinary shares, including exercisable options to purchase 69 ordinary shares.
|
(5)
|
Consists of 27,134 ordinary shares.
|
(6)
|
Consists of 15,656 ordinary shares.
|
(7)
|
Consists of 5,020 ordinary shares.
|
(8)
|
Mr. Marshall joined our Board of Directors on November 2, 2024.
|
(9)
|
Consists of 16,516 ordinary shares.
|
(10)
|
Consists of 18,641 ordinary shares.
|
(11)
|
Consists of 26,112 ordinary shares.
|
(12)
|
Consists of 7,142 ordinary shares.
|
(13)
|
Consists of (i) 220,075 ordinary shares directly or beneficially owned by our executive officers and our six directors other than Mr. Jasinski and (ii) 3,805 ordinary shares constituting the cumulative aggregate number of options granted to the executive officers and directors.
|
Options
|
Stock Awards
|
|||||||||||||||
Name and Position
|
Average
Exercise
Price
($)
|
Number of
Awards
(#)
|
Dollar Value
($)(1)
|
Number of
Awards
(#)
|
||||||||||||
Larry Jasinski, Chief Executive Officer
|
-
|
-
|
$
|
5.87
|
28,571
|
|||||||||||
Michael Lawless, Chief Financial Officer
|
-
|
-
|
$
|
4.20
|
23,571
|
|||||||||||
Jeannine Lynch, Vice President of Market Access and Strategy
|
-
|
-
|
$
|
4.20
|
19,642
|
|||||||||||
All current executive officers, as a group
|
-
|
-
|
$
|
4.44
|
(2)
|
126,784
|
||||||||||
All current directors who are not executive officers, as a group
|
-
|
-
|
$
|
5.87
|
(2)
|
42,658
|
||||||||||
All current employees and consultants who are not executive officers, as a group
|
-
|
-
|
$
|
4.28
|
(2)
|
81,472
|
|
(1) |
The valuation of share awards is based on the grant date fair value computed in accordance with FASB ASC Topic 718. For a discussion of the assumptions used in calculating these values, see Notes 2m and 9b to our consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2023.
|
|
(2) |
Represents the aggregate grant date fair value for the group.
|
|
• |
Shareholders whose shares are registered in their own name should contact Equiniti Trust Company, LLC by telephone at 1-800-937-5449 or by mail at 6201 15th Avenue, Brooklyn, N.Y. 11219, and inform it of their request; and
|
|
• |
Shareholders whose shares are held by a broker or other nominee should contact the broker or other nominee directly and inform them of their request.
|
By Order of the Board of Directors,
Joseph Turk
Chairman of the Board of Directors
|
(a)
|
give any Employee or Non-Employee Director the right to be retained in the service of the Company and/or an Affiliate, whether in any particular position, at any particular rate of compensation, for any particular period of time or otherwise;
|
|
(b) |
restrict in any way the right of the Company and/or an Affiliate to terminate, change or modify any Employee's employment or any Non-Employee Director's service as a Director at any time with or without cause;
|
|
(c) |
confer on any Consultant any right of continued relationship with the Company and/or an Affiliate, or alter any relationship between them, including any right of the Company or an Affiliate to terminate, change or modify its relationship with a Consultant;
|
|
(d) |
constitute a contract of employment or service between the Company or any Affiliate and any Employee, Non-Employee Director or Consultant, nor shall it constitute a right to remain in the employ or service of the Company or any Affiliate;
|
|
(e) |
give any Employee, Non-Employee Director or Consultant the right to receive any bonus, whether payable in cash or in Shares, or in any combination thereof, from the Company and/or an Affiliate, nor be construed as limiting in any way the right of the Company and/or an Affiliate to determine, in its sole discretion, whether or not it shall pay any Employee, Non-Employee Director or Consultant bonuses, and, if so paid, the amount thereof and the manner of such payment; or
|
|
(f) |
give any Participant any rights whatsoever with respect to an Award except as specifically provided in the Plan and the Award Agreement.
|
|
(a) |
determine which Affiliates shall be covered by the Plan;
|
|
(b) |
determine which Employees, Non-Employee Directors and/or Consultants are eligible to participate in the Plan;
|
|
(c) |
grant Awards (including substitutes for Awards), and modify the terms and conditions of any Awards, on such terms and conditions as the Committee determines necessary or appropriate to permit participation in the Plan by individuals otherwise eligible to so participate, or otherwise to comply with applicable laws or conform to applicable requirements or practices of the applicable jurisdictions;
|
|
(d) |
establish Subplans and adopt or modify exercise procedures and other terms and procedures, to the extent such actions may be necessary or advisable. Any subplans and modifications to Plan terms and procedures established under this Section 18.18 by the Committee shall be attached to the Plan as appendices; and
|
|
(e) |
take any action, before or after an Award is made, that the Committee, in its discretion, deems advisable to obtain approval or comply with any necessary local government regulatory exemptions or approvals.
|
1.
|
GENERAL
|
1.1. |
This appendix (the "Appendix") shall apply only to Israeli Participants (as defined below). The provisions specified hereunder shall form an integral part of the Lifeward Ltd. 2024 Incentive Compensation Plan (the "Plan"), which applies to the issuance of Awards to employees, directors, consultants and service providers of Lifeward Ltd. (the "Company") or its Affiliates.
|
1.2. |
This Appendix is effective with respect to Awards granted as of 30 days from the date it was submitted with the ITA and shall comply with Section 102 (as defined below).
|
1.3. |
This Appendix is to be read as a continuation of the Plan and only modifies Awards granted to Israeli Participants (as defined below) so that they comply with the requirements set by the Israeli law in general, and in particular with the provisions of Section 102 (as specified herein), as may be amended or replaced from time to time. For the avoidance of doubt, this Appendix does not add to or modify the Plan in respect of any other category of Participants.
|
1.4. |
The Plan and this Appendix are complementary to each other and shall be deemed as one. Subject to Section 1.3 above, in any case of contradiction, whether explicit or implied, between any definitions and/or provisions of this Appendix and the Plan, the provisions set out in this Appendix shall prevail.
|
1.5. |
Each capitalized term not specifically defined in this Appendix shall be construed according to the interpretation given to it in the Plan.
|
2. |
DEFINITIONS
|
2.1. |
"Affiliate" means any "employing company" within the meaning of Section 102(a) of the Ordinance.
|
2.2. |
"Approved 102 Award" means an Award granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of the Employee.
|
2.3. |
"Capital Gain Award (CGA)" means an Approved 102 Award elected and designated by the Company to qualify under the capital gain tax treatment in accordance with the provisions of Section 102(b)(2) of the Ordinance.
|
2.4. |
"Controlling Shareholder" shall have the meaning ascribed to it in Section 102 of the Ordinance.
|
2.5. |
"Employee" means an Israeli Participant who is employed by the Company or its Affiliates, including an individual who is serving as an "office holder" as defined in the Israeli Companies Law, 5759-1999, as amended from time to time, but excluding any Controlling Shareholder.
|
2.6. |
"Israeli Participant" means a person who is a resident of the state of Israel or who is deemed to be a resident of the state of Israel for Israeli tax purposes and receives or holds an Award under the Plan and this Appendix.
|
2.7. |
"ITA" means the Israel Tax Authority.
|
2.8. |
"Ordinary Income Award (OIA)" means an Approved 102 Award elected and designated by the Company to qualify under the ordinary income tax treatment in accordance with the provisions of Section 102(b)(1) of the Ordinance.
|
2.9. |
"102 Award" means any Award granted to Employees pursuant to Section 102 of the Ordinance and any other rulings, procedures and clarifications promulgated thereunder or issued by the ITA.
|
2.10. |
"3(i) Award" means an Award granted pursuant to Section 3(i) of the Ordinance to any person who is a Non-Employee.
|
2.11. |
"Israeli Award Agreement" means, for the purpose of this Appendix and notwithstanding Section 2.4 of the Plan, a written agreement entered into and signed by the Company and an Israeli Participant that sets out the terms and conditions of an Award.
|
2.12. |
"Non-Employee" means an Israeli Participant who is a consultant, adviser, service provider, Controlling Shareholder or any other person who is not an Employee.
|
2.13. |
"Ordinance" means the Israeli Income Tax Ordinance [New Version], 1961 as now in effect or as hereafter amended.
|
2.14. |
"Section 102" means section 102 of the Ordinance, the Income Tax Rules (Tax Relief for Issuance of Shares to Employees), 2003, and any other rules, regulations, orders or procedures promulgated thereunder as now in effect or as hereafter amended.
|
2.15. |
"Trustee" means any person appointed by the Company to serve as a trustee and approved by the ITA, all in accordance with the provisions of Section 102(a) of the Ordinance.
|
2.16. |
"Unapproved 102 Award" means an Award granted pursuant to Section 102(c) of the Ordinance and not held in trust by a Trustee.
|
3.
|
ISSUANCE OF AWARDS
|
3.1. |
Notwithstanding Article V of the Plan and in addition thereto, any Israeli Participants eligible for participation in the Plan and this Appendix as Israeli Participants shall include any Employee and/or Non-Employee of the Company or of any of the Company's Affiliates; provided, however, that (i) Employees may only be granted 102 Awards; and (ii) Non-Employees and/or Controlling Shareholders may only be granted 3(i) Awards.
|
3.2. |
The Company may designate Awards granted to Employees pursuant to Section 102 as Unapproved 102 Awards or Approved 102 Awards.
|
3.3. |
The grant of Approved 102 Awards shall be made under this Appendix and shall be conditioned upon the approval of this Appendix by the ITA.
|
3.4. |
Approved 102 Awards may either be classified as Capital Gain Awards ("CGAs") or Ordinary Income Awards ("OIAs").
|
3.5. |
No Approved 102 Awards may be granted under this Appendix to any eligible Employee, unless and until, the Company's election of the type of Approved 102 Awards as CGA or OIA granted to Employees (the "Election"), is appropriately filed with the ITA. Such Election shall become effective beginning the first date of grant of an Approved 102 Award under this Appendix and shall remain in effect until the end of the year following the year during which the Company first granted Approved 102 Awards. The Election shall obligate the Company to grant only the type of Approved 102 Award it has elected and shall apply to all Israeli Participants who were granted Approved 102 Awards during the period indicated herein, all in accordance with the provisions of Section 102(g) of the Ordinance. For the avoidance of doubt, such Election shall not prevent the Company from granting Unapproved 102 Awards simultaneously.
|
3.6. |
All Approved 102 Awards must be held in trust by a Trustee, as described in Section 4 below.
|
3.7. |
For the avoidance of doubt, the designation of Unapproved 102 Awards and Approved 102 Awards shall be subject to the terms and conditions set forth in Section 102.
|
4.
|
TRUSTEE
|
4.1. |
The terms and conditions applicable to the trust relating to Section 102 shall be set forth in an agreement signed by the Company and the Trustee (the "Trust Agreement").
|
4.2. |
Approved 102 Awards which shall be granted under this Appendix and/or any Shares allocated or issued upon exercise or vesting of such Approved 102 Awards and/or other rights granted thereunder and/or shares received subsequently following any realization of rights, including without limitation bonus shares, shall be allocated or issued to the Trustee and held for the benefit of the Employee for no less than such period of time as required by Section 102 (the "Holding Period"). In case the requirements for Approved 102 Awards are not met, then the Approved 102 Awards shall be regarded as Unapproved 102 Awards, all in accordance with the provisions of Section 102.
|
4.3. |
Notwithstanding anything to the contrary, the Trustee shall not release any Shares allocated or issued upon exercise or vesting of Approved 102 Awards prior to the full payment of the Employee's tax liabilities, if any, arising from Approved 102 Awards which were granted to him/her and/or any Shares allocated or issued upon exercise or vesting of such Awards.
|
4.4. |
With respect to any Approved 102 Award, subject to the provisions of Section 102, an Israeli Participant shall not sell or release from trust any Share received upon the exercise or vesting of an Approved 102 Award and/or any rights granted thereunder and/or share received subsequently following any realization of rights, including without limitation, bonus shares, until the lapse of the Holding Period required under Section 102. Notwithstanding the above, if any such sale or release occurs during the Holding Period, the sanctions under Section 102 shall apply to and shall be borne solely by such Israeli Participant. Subject to the foregoing, the Trustee may, pursuant to a written or electronic request from the Participant, release and transfer such Shares to a designated third party, provided that both of the following conditions have been fulfilled prior to such release or transfer: (i) payment has been made to the ITA of all taxes required to be paid upon the release and transfer of the Shares, and confirmation of such payment has been received by the Trustee and (ii) the Trustee has confirmed with the Company that all requirements for such release and transfer have been fulfilled according to the terms of the Company's corporate documents, the Plan, the Israeli Award Agreement and any Applicable Law.
|
4.5. |
Upon receipt of any Approved 102 Award, if requested to do so by the Company. Affiliate or the Trustee, the Employee will sign an undertaking to release the Trustee from any liability in respect of any action or decision duly taken and bona fide executed in relation with this Appendix, or any Approved 102 Award or Share granted to him thereunder.
|
4.6. |
Without derogating from the provisions of Article XVI of the Plan, the provisions of Section 16.1 of the Plan shall apply also to the Trustee. Accordingly, Trustee shall also have withholding rights as further described in Section 16.1 of the Plan.
|
4.7. |
In the case of 102 Awards, the Trustee shall have no rights as a shareholder of the Company with respect to the Shares covered by such Award until the Trustee becomes the record holder for such Shares for the Participant's benefit, and the Israeli Participant shall have no rights as a shareholder of the Company with respect to the Shares covered by the Award until the date of the release of such Shares from the Trustee to the Israeli Participant and the transfer of record ownership of such Shares to the Israeli Participant.
|
5.
|
THE AWARDS
|
6.
|
FAIR MARKET VALUE
|
7. |
EXERCISE OF AWARDS THAT ARE OPTIONS TO PURCHASE SHARES
|
8.
|
ASSIGNABILITY AND SALE OF AWARDS
|
8.1. |
Notwithstanding any other provision of the Plan, no Award or any right with respect thereto, or purchasable hereunder, whether fully paid or not, shall be assignable, transferable or given as collateral or any right with respect to them given to any third party whatsoever, and during the lifetime of the Israeli Participant each and all of such Israeli Participant's rights with respect to an Award shall belong only to the Israeli Participant.
|
8.2. |
As long as Awards or Shares purchased or issued hereunder are held by the Trustee on behalf of the Israeli Participant, all rights of the Israeli Participant over the Awards and/or Shares are personal, cannot be transferred, assigned, pledged or mortgaged, other than by will or laws of descent and distribution, provided that the transferee thereof shall be subject to the provisions of Section 102 as would have been applicable to the deceased Participant were he or she to have survived.
|
9.
|
INTEGRATION OF SECTION 102 AND TAX ASSESSING OFFICER'S PERMIT
|
9.1. |
With regards to Approved 102 Awards, the provisions of the Plan and/or the Appendix and/or the Israeli Award Agreement shall be subject to the provisions of Section 102 and the Tax Assessing Officer's permit and/or any pre-rulings obtained by the ITA, and the said provisions, permit and/or pre-rulings shall be deemed an integral part of the Plan and of the Appendix and of the Israeli Award Agreement.
|
9.2. |
Any provision of Section 102 and/or the said permit and/or pre-rulings which is necessary in order to receive and/or to keep any tax benefit pursuant to Section 102, which is not expressly specified in the Plan or the Appendix or the Israeli Award Agreement, shall be considered binding upon the Company and the Israeli Participants.
|
10.
|
DIVIDEND
|
11.
|
VOTING RIGHTS
|
12.
|
TAX CONSEQUENCES
|
12.1. |
Notwithstanding anything to the contrary in Article XVI of the Plan and solely for the purpose of Awards granted under this Appendix, any tax consequences arising from the grant, exercise or vesting of any Award, from the payment for Shares covered thereby or from any other event or act (of the Company, and/or its Affiliates, and the Trustee or the Israeli Participant), hereunder, shall be borne solely by the Israeli Participant. The Company and/or its Affiliates, and/or the Trustee shall withhold taxes according to the requirements under Applicable Law, including withholding taxes at source. Furthermore, the Israeli Participant hereby agrees to indemnify the Company and/or its Affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty or indexation thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Israeli Participant.
|
12.2. |
The Company and/or, when applicable, the Trustee shall not be required to release any share certificate to a Israeli Participant until all required payments have been fully made.
|
12.3. |
With respect to Unapproved 102 Award, if the Israeli Participant ceases to be employed by the Company or any Affiliate, the Israeli Participant shall extend to the Company and/or its Affiliate a security or guarantee for the payment of tax due at the time of sale of Shares, all in accordance with the provisions of Section 102 and the rules, regulation or orders promulgated thereunder.
|
12.4. |
Each Participant agrees to, and undertakes to comply with, any ruling, settlement, closing agreement or other similar agreement or arrangement with any tax authority in connection with the foregoing which is approved by the Company.
|
13.
|
ISRAELI PARTICIPANT'S UNDERTAKINGS
|
14.
|
TERM OF PLAN AND APPENDIX
|
15.
|
GOVERNING LAW & JURISDICTION
|
16.
|
NO PAYMENT FOR RESTRICTED SHARES AND RESTRICTED SHARE UNITS
|
17.
|
NO PAYMENTS IN CASH
|
1.
|
SPECIAL PROVISIONS FOR U.S. TAXPAYERS
|
1.1. |
This Appendix B (this "Appendix B") to the Lifeward Ltd. 2024 Incentive Compensation Plan (the "Plan") was adopted by the Board pursuant to Section 18.18 of the Plan. This Appendix B shall become effective on the Effective Date.
|
1.2. |
The provisions of this Appendix B apply only to Participants who are or may become subject to U.S. federal income tax (any such Participant, a "U.S. Taxpayer"). Grantees under this Appendix B will be such Employees, Non-Employee Directors or Consultants of the Company and its Affiliates as are selected from time to time by the Administrator in its sole discretion; provided that Awards may not be granted to Employees, Directors or Consultants who are providing services only to any "parent" of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i) the Shares underlying the Awards is treated as "service recipient stock" under Section 409A of the Code or (ii) the Company has determined that such Awards are exempt from or otherwise comply with Section 409A of the Code.
|
1.3. |
This Appendix B is to be read as a continuation of the Plan and only applies with respect to Options and other Awards granted under the Plan to U.S. Taxpayers. The purpose of this Appendix B is to establish certain rules and limitations applicable to Options and other Awards that may be granted or issued under the Plan to U.S. Taxpayers from time to time, in compliance with applicable tax, securities and other applicable laws currently in force. For the avoidance of doubt, this Appendix B does not add to or modify the Plan in respect of any other category of Israeli Participants (as defined in Appendix A to the Plan).
|
1.4. |
The Plan and this Appendix B are complementary to each other and shall be deemed as one. Subject to Section 1.3 of this Appendix B, in any case of contradiction, whether explicit or implied, between any definitions and/or provisions of this Appendix B and the Plan, the provisions set out in this Appendix B shall prevail.
|
1.5 |
Section references in this Appendix B shall refer to Sections of the Plan, unless expressly indicated otherwise.
|
2. |
DEFINITIONS
|
2.1. |
"Code" means the United States Internal Revenue Code of 1986, as it may be amended from time to time, including rules and regulations promulgated thereunder and successor provisions and rules and regulations thereto.
|
2.2. |
"Disability" means, for purposes of any ISO, a "permanent and total disability" as defined in Section 22(e)(3) of the Code.
|
2.3. |
"Fair Market Value" has the meaning assigned to such term in the Plan; provided that the Committee shall determine Fair Market Value in a manner that satisfies the applicable requirements of Code Sections 409A and 422.
|
2.4. |
"Incentive Stock Option" or "ISO" means a right to purchase Shares under the Plan in accordance with the terms and conditions set forth in Article VI of the Plan and which is designated as an Incentive Stock Option and which is intended to meet the requirements of Section 422 of the Code.
|
2.5. |
"Nonqualified Stock Option" or "NQSO" means a right to purchase Shares under the Plan in accordance with the terms and conditions set forth in Article VI of the Plan and which is not intended to meet the requirements of Section 422 of the Code or otherwise does not meet such requirements.
|
2.6. |
"Subsidiary" means any present or future corporation which is or would be a "subsidiary corporation" of the Company as the term is defined in Section 424(f) of the Code.
|
3.
|
INCENTIVE STOCK OPTIONS
|
3.1. |
Any Substitute Awards granted under the Plan shall be subject to compliance with the ISO rules under Code Sections 422 and 424 and the nonqualified deferred compensation rules under Code Section 409A, where applicable.
|
3.2. |
The provisions of Section 4.2 of the Plan shall, in the case of ISOs, be subject to any limitations applicable thereto under the Code.
|
3.3. |
The total number of Shares that may be delivered pursuant to Incentive Stock Options granted under the Plan shall be the number of Shares determined in accordance with Section 4.1 of the Plan, as adjusted pursuant to Section 4.2 of the Plan, but without application of Section 4.2(d) of the Plan.
|
3.4. |
The Committee shall determine any adjustment, substitution or change pursuant to Section 4.3 of the Plan after taking into account, among other things, to the extent applicable, the provisions of the Code applicable to Incentive Stock Options and the provisions of Section 409A of the Code.
|
3.5. |
Each Award Agreement relating to an Option shall specify whether such Option is intended to be an ISO or an NQSO. To the extent that any Option granted to a U.S. Taxpayer does not qualify as an ISO (whether because of its provisions or the time or manner of its exercise or otherwise), such Option, or the portion thereof which does not so qualify, shall constitute a separate NQSO.
|
3.6. |
No ISO shall be exercisable later than the tenth (10th) anniversary of its date of grant.
|
3.7 |
The last sentence of Section 6.5 of the Plan shall not apply to ISOs.
|
3.8. |
The right to make a payment of the Option Price of an Incentive Stock Option in the form of already owned Shares, under Section 6.6(a) of the Plan, may be authorized only as of the grant date of such Incentive Stock Option.
|
3.10. |
No ISO shall be granted to any individual otherwise eligible to participate in the Plan who is not an Employee of the Company or a Subsidiary on the date of granting of such Option. Any ISO granted under the Plan shall contain such terms and conditions, consistent with the Plan, as the Committee may determine to be necessary to qualify such Option as an "incentive stock option" under Section 422 of the Code. Any ISO granted under the Plan may be modified by the Committee to disqualify such Option from treatment as an "incentive stock option" under Section 422 of the Code.
|
3.11. |
Notwithstanding any intent to grant ISOs, an Option granted under the Plan will not be considered an ISO to the extent that it, together with any other "incentive stock options" (within the meaning of Section 422 of the Code) under the Plan and any other "incentive stock option" plans of the Company, any Subsidiary and any "parent corporation" of the Company within the meaning of Section 424(e) of the Code, are exercisable for the first time by any Participant during any calendar year with respect to Shares having an aggregate Fair Market Value in excess of $100,000 (or such other limit as may be required by the Code) as of the time the Option with respect to such Shares is granted. The rule set forth in the preceding sentence shall be applied by taking Options into account in the order in which they were granted.
|
3.12. |
No ISO shall be granted to an individual otherwise eligible to participate in the Plan who owns (within the meaning of Section 424(d) of the Code), at the time the Option is granted, more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or a Subsidiary or any "parent corporation" of the Company within the meaning of Section 424(e) of the Code. This restriction does not apply if at the time such ISO is granted the Option Price of the ISO is at least 110% of the Fair Market Value of a Share on the date such ISO is granted, and the ISO by its terms is not exercisable after the expiration of five years from such date of grant.
|
3.13. |
Notwithstanding any other provision of the Plan to the contrary, with respect to a Tandem SAR granted in connection with an ISO: (i) the Tandem SAR will expire no later than the expiration of the related ISO; (ii) the value of the payment with respect to the Tandem SAR may not exceed the difference between the Fair Market Value of the Shares subject to the related ISO at the time the Tandem SAR is exercised and the Option Price of the related ISO; and (iii) the Tandem SAR may be exercised only when the Fair Market Value of the Shares subject to the ISO exceeds the Option Price of the ISO.
|
3.14. |
No ISO or Tandem SAR granted in connection with an ISO may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution or in accordance with Section 12.2 of the Plan. Further, all ISOs and Tandem SARs granted in connection with ISOs granted to a Participant shall be exercisable during his or her lifetime only by such Participant.
|
3.15. |
The Committee may require a Participant to give prompt written notice to the Company concerning any disposition of Shares received upon the exercise of an ISO within (i) two (2) years from the date of granting such ISO to such Participant or (ii) one (1) year from the transfer of such Shares to such Participant or (iii) such other period as the Committee may from time to time determine. The Committee may direct that a Participant with respect to an ISO undertake in the applicable Award Agreement to give such written notice described in the preceding sentence, at such time and containing such information as the Committee may prescribe, and/or that the certificates evidencing Shares acquired by exercise of an ISO refer to such requirement to give such notice.
|
4.
|
GRANT DATE FAIR MARKET OPTION PRICE AND GRANT PRICE; TERM
|
4.1 |
No Option or SAR shall be granted pursuant to this Appendix B unless the Option Price of such Option or the Grant Price of such SAR, as the case may be, shall be not less than one hundred percent (100%) of the Fair Market Value of a Share on the Grant Date of such Option or SAR. Notwithstanding the foregoing, Options or SARs may be granted with an Option Price that is less than 100 hundred percent (100%) of the Fair Market Value of a Share on the Grant Date (i) pursuant to a transaction described in, and in a manner consistent with, Section 424(a) of the Code, or (ii) the Stock Option is otherwise compliant with Section 409A.
|
4.2 |
Subject to Section 3.12 of this Appendix B, the term of an Option or SAR may not exceed ten years.
|
5.
|
DEFERRED COMPENSATION
|
5.1. |
It is the intention of the Company that no Award shall be deferred compensation subject to Code Section 409A unless and to the extent that the Committee specifically determines otherwise as provided in Section 5.2 of this Appendix B, and the Plan and the terms and conditions of all Awards shall be interpreted and administered accordingly
|
5.2. |
The terms and conditions governing any Awards that the Committee determines will be subject to Section 409A of the Code, including any rules for payment or elective or mandatory deferral of the payment or delivery of Shares or cash pursuant thereto, and any rules regarding treatment of such Awards in the event of a Change of Control, shall be set forth in the applicable Award Agreement and shall be intended to comply in all respects with Section 409A of the Code, and the Plan and the terms and conditions of such Awards shall be interpreted and administered accordingly.
|
5.3. |
The Committee shall not extend the period to exercise an Option or Stock Appreciation Right to the extent that such extension would cause the Option or Stock Appreciation Right to become subject to Code Section 409A.
|
5.4. |
No Dividend Equivalents shall relate to Shares underlying an Option or SAR unless such Dividend Equivalent rights are explicitly set forth as a separate arrangement and do not cause any such Option or SAR to be subject to Code Section 409A.
|
5.5 |
The Company shall have complete discretion to interpret and construe the Plan and any Award Agreement in any manner that establishes an exemption from (or compliance with) the requirements of Code Section 409A. If for any reason, such as imprecision in drafting, any provision of the Plan and/or any Award Agreement does not accurately reflect its intended establishment of an exemption from (or compliance with) Code Section 409A, as demonstrated by consistent interpretations or other evidence of intent, such provision shall be considered ambiguous as to its exemption from (or compliance with) Code Section 409A and shall be interpreted by the Company in a manner consistent with such intent, as determined in the discretion of the Company. If, notwithstanding the foregoing provisions of this Section 5.5, any provision of the Plan or any Award Agreement would cause a Participant to incur any additional tax or interest under Code Section 409A, the Company shall reform such provision in a manner intended to avoid the incurrence by such Participant of any such additional tax or interest; provided that the Company shall maintain, to the extent reasonably practicable, the original intent and economic benefit to the Participant of the applicable provision without violating the provisions of Code Section 409A.
|
5.6. |
Notwithstanding the provisions of Section 4.3 of the Plan to the contrary, (1) any adjustments made pursuant to Section 4.3 of the Plan to Awards that are considered "deferred compensation" subject to Section 409A of the Code shall be made in compliance with the requirements of Section 409A of the Code; (2) any adjustments made pursuant to Section 4.3 of the Plan to Awards that are not considered "deferred compensation" subject to Section 409A of the Code shall be made in such a manner as to ensure that after such adjustment, the Awards either (A) continue not to be subject to Section 409A of the Code or (B) comply with the requirements of Section 409A of the Code; and (3) in any event, neither the Committee nor the Board shall have any authority to make any adjustments, substitutions or changes pursuant to Section 4.3 of the Plan to the extent the existence of such authority would cause an Award that is not intended to be subject to Section 409A of the Code at the Grant Date thereof to be subject to Section 409A of the Code.
|
5.7. |
If any Award is subject to Section 409A of the Code, the provisions of Article XIV of the Plan shall be applicable to such Award only to the extent permitted pursuant to Section 5.2 of this Appendix B or otherwise permitted in accordance with the requirements of Section 409A.
|
6.
|
RESTRICTED SHARE UNITS
|
6.1 |
The following shall apply to the grant of Restricted Share Units to US Taxpayers pursuant to this Appendix B. In the event that Article VIII of the Plan conflicts with this Section 6 of the Appendix B, this Section 6 shall control with respect to Restricted Share Units that have been granted to US Taxpayers. A Restricted Share Unit may be settled in Shares (or cash, to the extent explicitly provided for in the Award Agreement) upon the lapse of the Period of Restriction. Except in the case of Restricted Share Units with a deferred settlement date that complies with Section 409A of the Code, at the end of the Period of Restriction, the Restricted Share Units, to the extent vested, shall be settled in the form of Shares. Restricted Share Units with deferred settlement dates are subject to Section 409A of the Code and shall contain such additional terms and conditions as the Committee shall determine in its sole discretion in order to comply with the requirements of Section 409A of the Code.
|
6.2 |
In addition, the Committee may, in its sole discretion, permit a Participant to elect to receive a portion of future cash compensation otherwise due to such Participant in the form of an award of Restricted Share Units. Any such election shall be made in writing and shall be delivered to the Company no later than the date specified by the Committee and in accordance with Section 409A of the Code and such other rules and procedures established by the Committee. Any such future cash compensation that the Participant elects to defer shall be converted to a fixed number of Restricted Share Units based on the Fair Market Value of a Share on the date the compensation would otherwise have been paid to the Participant if such payment had not been deferred as provided herein. The Committee shall have the sole right to determine whether and under what circumstances to permit such elections and to impose such limitations and other terms and conditions thereon as the Committee deems appropriate. Any Restricted Share Units that are elected to be received in lieu of cash compensation shall be fully vested, unless otherwise provided in the Award Agreement.
|
7. |
SECTION 83(B) ELECTION
|
8. |
ADJUSTMENTS
|
9. |
GOVERNING LAW AND JURISDICTION
|
THE BOARD OF DIRECTORS OF THE COMPANY RECOMMENDS A VOTE "FOR" THE FOLLOWING PROPOSALS.
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE: ☒
|
|
|
|
|
FOR
|
AGAINST
|
ABSTAIN
|
|
|
1. |
To amend the Company's Sixth Amended and Restated Articles of Association to eliminate the par value of the Company's ordinary shares.
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
|
|
|
2. |
To approve the Company's 2024 Incentive Compensation Plan.
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
|
|
|
3. |
To approve a grant to Larry Jasinski, the Company's Chief Executive Officer, of 14,286 restricted stock units ("RSUs") and 14,285 performance-based RSUs.
|
☐ | ☐ | ☐ |
|
|
|
|
|
|
|
|
|
|
By executing this proxy card, you will be deemed to confirm that you are NOT a Controlling Shareholder and do NOT have a Personal Interest (as such terms are defined in the Proxy Statement) in the approval of Proposal 3. If you are a Controlling Shareholder or have a Personal Interest (in which case your vote will count only for or against the Ordinary Majority, and not for or against the Special Majority, required for approval of Proposal 3), please notify the Company as described on the reverse side of this proxy card.
|
|
|
|
To change the address on your account, please check the box at right and indicate your new address in the address space above. Please note that changes to the registered name(s) on the account may not be submitted via this method.
|
☐ |
|
|
|
|
|
|
|
|
|
Signature of Shareholder
|
|
Date:
|
|
Signature of Shareholder
|
|
Date:
|
|
Note:
|
Please sign exactly as your name or names appear on this Proxy. All holders must sign. When shares are held jointly, the senior of the joint holders must sign. When signing as executor, administrator, attorney, trustee, guardian or other fiduciary, please give full title as such. If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
|